My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 5:13 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Obagi Medical Products, Inc.
Obagi Medical Products, Inc. (OMPI.O) (Nasdaq)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
OMPI
on other exchanges
As of 25 Nov 2009
11.18
USD
Price Change
-0.12
Percent Change
-1.06%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Dec 2008
Badie, Ronald
--
--
--
--
Bartholdson, John
--
--
--
--
Carlson, Steven
483,353
--
12,508
495,861
Duerden, John
--
--
--
--
Fitzgibbons, Albert
--
--
--
--
Goldstein, David
292,532
--
148,083
440,615
Grant, Edward
--
--
--
--
Hummel, Albert
--
--
--
--
Hunter, Laura
86,667
--
26,610
113,277
Romm, Preston
159,235
--
100,613
259,848
Find out more about OMPI.O
Insider Trading